Qi deficiency and blood stasis type ischemic stroke with constipation
Conditions
Interventions
control group:1.2.1.1 Basic Treatment All enrolled patients received corresponding stroke unit–based treatment according to their clinical conditions. 1.2.1.2 Basic Nursing Care According to the Trad
2) Patients were advised to consume more high-fiber foods and foods that promote bowel movements. For patients with qi-deficiency constipation, diets that tonify qi and blood and moisten the intestine
3) Patients were instructed to defecate at fixed times daily to help re-establish regular bowel habits. 1.2.1.3 Acupoint Application Therapy Acupoint application was performed by uniformly trained nu
experimental group:1.2.1 Interventions for Both Groups 1.2.1.1 Basic Treatment All enrolled patients received corresponding stroke unit–bas
Sponsors
Wenzhou Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients who met the diagnostic criteria for stroke and constipation in both Western medicine and traditional Chinese medicine (TCM), and were diagnosed with the TCM syndrome of qi deficiency and blood stasis in stroke; (2) Patients without a history of constipation prior to stroke onset; (3) Patients aged 40–80 years, of either sex, who were able to cooperate with treatment; (4) Patients with a duration of stroke ranging from 2 weeks to 6 months; (5) Patients who were conscious, with stable vital signs, and able to complete the required assessments; (6) Patients and their families who voluntarily agreed to participate in this clinical trial and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who had participated in other constipation-related clinical trials or received related treatments within the past 1 month that might affect the outcomes of this study; (2) Patients with severe systemic diseases or psychiatric disorders; (3) Patients with hematological disorders or a tendency to bleed; (4) Patients with long-term use of laxatives resulting in drug-dependent constipation; (5) Patients with confirmed organic lesions of the rectum, colon, or other intestinal structures; (6) Patients with constipation caused by tumors or medications, or those diagnosed with irritable bowel syndrome (IBS); (7) Patients with skin damage at the treatment site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Constipation Symptoms and Therapeutic Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life in Patients with Constipation;Halitosis as an Associated Symptom of Constipation;Patient Satisfaction; | — |
Countries
China
Contacts
Public ContactZhou Xianxian
Wenzhou Hospital of Traditional Chinese Medicine, Affiliated to Zhejiang Chinese Medical University
Outcome results
None listed